Brevan Howard Capital Management’s Cohen & Steers CNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$422K Sell
5,541
-2,083
-27% -$147K ﹤0.01% 1525
2026
Q1
$477K Sell
7,624
-5,579
-42% -$364K ﹤0.01% 1328
2025
Q4
$829K Sell
13,203
-751
-5% -$48.9K 0.01% 856
2025
Q3
$916K Buy
13,954
+4,603
+49% +$337K ﹤0.01% 943
2025
Q2
$705K Buy
+9,351
New +$719K ﹤0.01% 1223
2025
Q1
Sell
-5,096
Closed -$471K 1198
2024
Q4
$471K Buy
+5,096
New +$504K ﹤0.01% 645
2024
Q2
Sell
-5,692
Closed -$438K 1104
2024
Q1
$438K Buy
+5,692
New +$406K ﹤0.01% 502

Other funds holding CNS

Brevan Howard Capital Management's CNS Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Cohen & Steers (CNS) stake by 27% in Q2 2026, selling an estimated $147K and leaving 5,541 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.

Brevan Howard Capital Management first reported a position in CNS in Q1 2024 and has held it in 7 quarters since. The position peaked at $916K in Q3 2025. 311 funds tracked by Wall St. Rank hold CNS as of Q2 2026.

  • Brevan Howard Capital Management held 5,541 shares of Cohen & Steers worth $422K as of Q2 2026.
  • Brevan Howard Capital Management sold 2,083 Cohen & Steers shares in Q2 2026, an estimated $147K.
  • Cohen & Steers made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1525 holding.
  • Brevan Howard Capital Management first reported a position in Cohen & Steers in Q1 2024 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Cohen & Steers position peaked at $916K in Q3 2025.
  • 311 funds tracked by Wall St. Rank held Cohen & Steers as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.